Windtree Therapeutics, Inc. is a clinical-stage biotechnology and medical device company dedicated to advancing innovative therapies for acute pulmonary and cardiovascular diseases. With a strong emphasis on addressing unmet medical needs, the company is advancing its proprietary product candidates through various stages of clinical development. Windtree's unique approach combines advanced therapeutic modalities and devices, positioning it for potential significant impact in the healthcare market. The company's commitment to improving patient outcomes underscores its strategic focus on delivering life-changing treatments.
Click "Analyze" to generate stock analysis
WINT Price Trend and Signals
WINT Financials
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-08-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.